Regulatory Roundup: ISPE to Hold Risk-MaPP 2010 Conference - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Regulatory Roundup: ISPE to Hold Risk-MaPP 2010 Conference

ePT--the Electronic Newsletter of Pharmaceutical Technology

Untitled Document

The International Society for Pharmaceutical Engineering (ISPE) will host the ISPE Risk-MaPP 2010 Conference, Dedicated Facilities, Cross Contamination and the Risk-MaPP Approach in Washington, DC, on October 4–5 2010. The group will hold the North American launch of the new ISPE Baseline Guide: Risk-Based Manufacturing of Pharmaceutical Products (Risk-MaPP) at the conference, and attendees will receive a complimentary downloadable copy of the guide. To register for the conference, click here.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here